Turning Point Therapeutics logo
Turning Point Therapeutics TPTX

Quartalsbericht 2022-Q2
hinzugefügt 08.08.2022

report update icon

Turning Point Therapeutics Langfristiger Schuldenstrom 2011-2026 | TPTX

Langfristiger Schuldenstrom Jährlich Turning Point Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.63 M 1.4 M 1.24 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
3.63 M 1.24 M 2.09 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 21.75 1.59 % $ 1.02 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.91 1.61 % $ 6.69 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.29 1.5 % $ 3.69 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 102.75 -2.57 % $ 27.2 B germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.1 0.37 % $ 438 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.2 -0.26 % $ 2.95 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.42 -1.39 % $ 378 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.99 2.75 % $ 4.92 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
671 K - -5.16 % $ 5.39 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
730 K $ 1.72 -0.29 % $ 115 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
65 K $ 1.07 0.94 % $ 13.1 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 2.96 0.17 % $ 297 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
116 K - -3.03 % $ 260 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 1.95 1.83 % $ 405 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
1.06 M - - $ 35.4 M usaUSA